Scardino A, Paroli M, De Petrillo G, Michel M L, Barnaba V
Fondazione Andrea Cesalpino, I Clinica Medica, Università La Sapienza, Rome, Italy.
Immunology. 1994 Jan;81(1):167-70.
Receptor-mediated uptake increases by several orders of magnitude the efficiency of APC to internalize Ag, and is stringently required for the Ag-presenting function of T lymphocytes due to their inability to take up Ag non-specifically. We have previously reported that hepatitis B envelope antigen (HBenvAg) can be internalized by T cells via transferrin receptor (TfR). To evaluate if Ag targeting to receptors expressed on APC could be an effective tool for promoting Ag uptake and presentation, we tested the capacity of activated T cells not expressing TfR to induce HBenvAg-specific T-cell responses when pulsed with a hybrid particle containing HBenvAg coupled to gp120 of human immunodeficiency virus (HIV), exploiting the ability of gp120 to bind to CD4 receptor. We found that CD4+/TfR- T cells pulsed either with the hybrid particle or peptide (S193-207) but not with S, L Ag, a recombinant form of HBenvAg, induced a specific proliferative response of a T-cell clone recognizing peptide (S193-207) of HBenvAg. The finding that the addition of anti-CD4 monoclonal antibody (mAb) before the pulsing of CD4+/TfR- T cells with the hybrid particle drastically blocked the specific T-cell response, together with the finding that CD8+/TfR- T cells were unable to serve as APC even if pulsed with this molecule, demonstrated that CD4 receptor was crucial for the HBenvAg internalization. On the other hand, HBenvAg presentation by CD4+/TfR+ T cells pulsed with the hybrid particle was inhibited only when both anti-CD4 and anti-TfR were added before the pulsing. These results suggest that Ag targeting to APC receptors may be usefully exploited to improve Ag-presentation efficiency in potential immunotherapeutic approaches.
受体介导的摄取使抗原呈递细胞内化抗原的效率提高了几个数量级,由于T淋巴细胞无法非特异性摄取抗原,因此这对于T淋巴细胞的抗原呈递功能是严格必需的。我们之前报道过,乙型肝炎表面抗原(HBenvAg)可通过转铁蛋白受体(TfR)被T细胞内化。为了评估靶向抗原呈递细胞上表达的受体是否可能是促进抗原摄取和呈递的有效工具,我们测试了不表达TfR的活化T细胞在用含有与人类免疫缺陷病毒(HIV)的gp120偶联的HBenvAg的杂交颗粒脉冲时,诱导HBenvAg特异性T细胞反应的能力,利用gp120与CD4受体结合的能力。我们发现,用杂交颗粒或肽(S193 - 207)而非HBenvAg的重组形式S、L抗原脉冲的CD4 + /TfR - T细胞,诱导了识别HBenvAg肽(S193 - 207)的T细胞克隆的特异性增殖反应。在用杂交颗粒脉冲CD4 + /TfR - T细胞之前添加抗CD4单克隆抗体(mAb)会显著阻断特异性T细胞反应,以及CD8 + /TfR - T细胞即使被该分子脉冲也无法作为抗原呈递细胞的发现,都证明了CD4受体对于HBenvAg的内化至关重要。另一方面,仅在用杂交颗粒脉冲之前同时添加抗CD4和抗TfR时,用杂交颗粒脉冲的CD4 + /TfR + T细胞的HBenvAg呈递才会受到抑制。这些结果表明,在潜在的免疫治疗方法中,靶向抗原呈递细胞受体的抗原可能会被有效地用于提高抗原呈递效率。